RT Journal Article SR Electronic T1 Human health effects of recycling and reusing plastic packaging in the food system: a systematic review and meta-analysis of life cycle assessments JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2022.04.22.22274074 DO 10.1101/2022.04.22.22274074 A1 Megan Deeney A1 Rosemary Green A1 Xiaoyu Yan A1 Claire Dooley A1 Joe Yates A1 Heike B Rolker A1 Suneetha Kadiyala YR 2022 UL http://medrxiv.org/content/early/2022/04/23/2022.04.22.22274074.abstract AB Circular strategies, including recycling and reuse of food packaging, are critical responses to the plastic pollution crisis and could provide co-benefits and trade-offs for human health. Our meta-analysis of life cycle assessment (LCA) data quantifies possible health effects using Disability-Adjusted Life Years (DALYs) mediated by climate change, ozone, air pollution, toxicity, and water scarcity. We found strong evidence for reduced health risks with both a higher percentage of recycled content and a greater end-of-life recycling rate, resulting in around a day of healthy life saved per tonne of plastic packaging recycled. On average, reusable packaging reduced the health impacts associated with single use plastics after 30 uses, which is unlikely reflected in current consumer behaviour. Data from low- and middle-income countries, and greater use of health indicators in LCA, are urgently needed. LCA is a unique tool that could be optimised for interdisciplinary public health research on circular economies.Teaser Life cycle assessment meta-analysis shows recycling and reusing plastic food packaging could provide human health co-benefits, and some risks.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is funded through the Innovative Methods and Metrics for Agriculture and Nutrition Action (IMMANA) programme, led by the London School of Hygiene & Tropical Medicine (LSHTM). IMMANA is co-funded by: UK Foreign Commonwealth and Development Office (FCDO) grant 300654 (SK, JY, MD) Bill & Melinda Gates Foundation INV-002962 / OPP1211308 (SK, JY, MD)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors